urinary cyclic guanosine monophosphate

Cyclic guanosine monophosphate is produced by intracellular guanosine triphosphate (GTP) catalyzed by guanylate cyclase. It is believed that cyclic guanosine monophosphate and cyclic adenosine monophosphate are mutually antagonistic substances. Under normal physiological conditions, the ratio of cyclic adenosine monophosphate to cyclic guanosine monophosphate in tissue or plasma remains relatively constant, and is often determined simultaneously in the analysis. The concentration of these two substances, the imbalance between the two is an objective indicator of the pathogenesis of certain diseases. Basic Information Specialist classification: growth and development check classification: urine / kidney function test Applicable gender: whether men and women apply fasting: fasting Analysis results: Below normal: Hypothyroidism, hypoparathyroidism. Normal value: Urinary ring guanosine monophosphate: 0.22-0.68 μmol/g·creatinine Above normal: Hyperthyroidism, hyperparathyroidism, cirrhosis, malignancy. negative: Positive: Tips: Do not exercise vigorously, maintain a good diet and work. The middle part of the urine is taken for inspection. Women in the menstrual period are not suitable for this examination. Normal value 0.22 to 0.68 μmol/g·creatinine. Clinical significance (1) elevated: hyperthyroidism, hyperparathyroidism, cirrhosis, malignant tumors. (2) reduction: hypothyroidism, hypoparathyroidism. Low results may be diseases: hypothyroidism, hyperparathyroidism results may be high disease: liver cirrhosis, hyperthyroidism Before the test: Do not exercise vigorously, maintain a good diet and rest. At the time of examination: a part of the urine is discharged first to wash away the bacteria remaining in the urethra and the anterior urethra, and then the middle part of the urine is taken for inspection. Inspection process The urine of the subject was collected and detected by enzymatic method. Not suitable for the crowd Not suitable for the crowd: women in the menstrual period. Adverse reactions and risks No.